|
A sudden throttling pain ran through Mr. Verma’s chest at midnight. He
woke up to find himself in a pool of sweat and a heaviness and extreme
discomfort in his chest, suffocation and palpitations.
He was rushed to the ICU & treated for acute myocardial
infarction.
After discharge Mr. Verma continued to have symptoms of ischemic heart
disease such as chest pain and raised B. P. He could not return to his
job. He had insomnia, loss of appetite, decreased interest and reduced
energy.
Finally he consulted a psychiatrist and was started on antidepressant
medication. Within a month he was back at his job and his cardiac symptoms
had also improved considerably.
Cardiovascular disease frequently co-exists with psychiatric disorders.
Of all parts of the body the heart holds a place of special distinction in
common thinking as the seat of emotion, effort and even of life itself.
Prevalence of depression in patients of cardiovascular disease is at
least 20%.
DEPRESSION AS A CAUSE OF CARDIOVASCULAR DISEASE
There is overwhelming evidence from community based studies that there
is a 1.5-2 fold increase in mortality among patients with depression and
this excess is primarily from cardiovascular deaths. Various reasons cited
for this include:
- Increased smoking in depressed people
- Fluctuation of blood pressure
- Obesity due to decreased physical ctivity
- Increased serum cholesterol because of lipid release from deposits
during stress produced as a result of depression
- Increased atherogenesis (increased fatty deposits in blood vessels)
- Increased platelet aggregation
Thus a 65% increase in risk of ischemic disease is associated with depression.
DEPRESSION AS A CONSEQUENCE OF CARDIOVASCULAR DISEASE
Following cardiovascular diseases like acute myocardial infarction,
many patients are forced to be dependent on others. They contribute less
to the support of their families. Sexual function may be adversely
affected.
Smoking, alcohol use, failure to exercise and non-compliance with
medication or diet have contributed to development of illness and may
result in feelings of guilt.
The issues of progression of disease, recurrence and death are
universally present for heart disease patients and may be met with
reactions such as denial, anxiety and depression.
EFFECTS OF DEPRESSION ON THE OUTCOME OF CARDIOVASCULAR
DISEASE
It has been proved beyond doubt that the presence of depression after
myocardial infarction increases the risk of mortality to almost 4:1 at 6
months follow-up. The patients at greatest risk of mortality are those
with combination of significant premature ventricular cardiovascular
disease (PVCs) and depression. There might be an arrhythmic relationship
between depression and sudden death.
Other Consequences
- Inadequate response to therapy due to poor patient compliance to
cardiac treatment and rehabilitation regimens. Also there may be
problems in doctor-patient relationship. All these lead to persistence
of cardiovascular symptoms and prolonged treatment.
- Poor quality of life and increased disability
- Decreased level of functioning. The patients cannot resume their
previous jobs.
- Adjustment disorders with family members
- Restricted social life.
DIAGNOSTIC CRITERIA
Diagnosis of co-morbid depression with cardiovascular disease is
difficult because many of the symptoms overlap both the diseases. However
clinicians are urged to aggressively and proactively identify depressive
symptoms whether they appear from cardiovascular disease or not. The
various symptoms include:
- Insomnia - usually waking in the morning at least 2 hours before the usual time
- Feeling of apprehension and tension
- Loss of interest and enjoyment
- Decreased energy causing tiredness and decrease in activity
- Decreased attention and concentration
- Ideas of guilt and worthlessness
- Decreased self-esteem
- Somatic symptoms such as backache, headache, dizziness, GI distress.
The clinician can pay attention to the following to help the diagnosis:
- Prior history of depressive episode in the patient
- Positive family history of depression
- Female gender
- Time of onset of depressive symptoms (prior to onset of medical illness)
- Duration of current depressive episode (>2 weeks) and pervasive throughout the day
It is far better to over diagnose depression than to under diagnose since if depression is present, regardless of etiology, it requires
proactive diagnosis and treatment.
MANAGEMENT
The aggressive management of depression is extremely essential to
improve the outcome of co-morbid cardiovascular disease.
1.PHARMACOTHERAPY - ANTIDEPRESSANTS
- Dothiepin is an effective antidepressant in cardiovascular disease.
- Selective serotonin re-uptake inhibitors (SSRI) such as fluoxetine (20-60 mg/d),
paroxetine, sertraline have been found to have the safest cardiovascular profile. They
are well tolerated in patients with stable heart disease & left ventricular dysfunction.
- Amongst the tricyclic anti-depressants, nortryptiline is safer than
others. However it may have certain cardiac side-effects.
- Nefazodone also has no reported cardiac effects.
2.PSYCHOTHERAPY
- Establish rapport between the doctor and the patient
- Education of the patient regarding medication and dietary factors.
- Morale boosting of the patient
- Psychological support system to deal with problems at work, sexual
life, physical complaints and mortality
- Relaxation, Cognitive and Behavior therapy, Stress
Management
|